Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.
Nie E, Miao F, Jin X, Wu W, Zhou X, Zeng A, Yu T, Zhi T, Shi Z, Wang Y, Zhang J, Liu N, You Y.
Nie E, et al. Among authors: miao f.
Oncogene. 2019 Apr;38(15):2706-2721. doi: 10.1038/s41388-018-0596-2. Epub 2018 Dec 12.
Oncogene. 2019.
PMID: 30542120
Free PMC article.